SV

Street Verdict

Analyst Scorecard

A record of what Prabhudas Lilladher Analysis said publicly, with the source. Not advice.

“Recommends buying Krishna Institute of Medical Sciences (KIMS) with a target price of ₹725. The call is based on the firm's research, indicating a positive outlook for the stock.”

Prabhudas Lilladher Analysis’s track record (trackable calls only): 300 graded calls · 95% CI 43–54%

Krishna Institute of Medical SciencesBullishCalled 01 Jul 2025
Verdict:PENDING

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹725, as stated.

Window: 12 months, the default when no time frame is stated.

Window still open: no verdict until a close reaches a level or the window ends.

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Tracking Krishna Institute of Medical Sciences since this call

1-year tracking window
Read the original articleSee Prabhudas Lilladher Analysis’s full track record